PHRX.CN Stock - Pharmadrug Inc.
Unlock GoAI Insights for PHRX.CN
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $7,009 | $683,671 |
| Gross Profit | $-50,244 | $-26,216 | $-2,263 | $-2,155 | $182,037 |
| Gross Margin | N/A | N/A | N/A | -30.7% | 26.6% |
| Operating Income | $-668,658 | $-1,335,000 | $-2,430,000 | $-2,796,000 | $-3,839,000 |
| Net Income | $-793,267 | $-13,201,000 | $-8,876,000 | $-5,874,000 | $-5,150,000 |
| Net Margin | N/A | N/A | N/A | -83806.5% | -753.3% |
| EPS | $-0.01 | $-0.23 | $-0.13 | $-0.12 | $-0.25 |
Pharmadrug Inc. operates as a specialty pharmaceutical company. It focuses on the research, development, and commercialization of controlled-substances and natural medicines, such as psychedelics, cannabis, and naturally-derived approved drugs. It also imports and distributes medical cannabis to pharmacies in Germany and rest of the European Union; and owns and operates Super Smart, an entity building to elevate the use of functional mushrooms and psilocybin mushrooms. In addition, the company engages in the researching and reformulating established natural medicines. It has a research agreement with the University of Michigan to evaluate N, N-dimethyltryptamine's (DMT) potential role in normal, diseased, and altered states of consciousness, as well as an agreement with Southwest Research Institute for initiating non-clinical and clinical manufacturing of cepharanthine; and clinical trial agreement with Johns Hopkins University to conduct a clinical study comparing acute and enduring psychological and neural effects of DMT and an undisclosed potently active comparator molecule. The company was formerly known as Aura Health Inc. and changed its name to Pharmadrug Inc. in October 2019. The company is based in Toronto, Canada.
Visit WebsiteEarnings History & Surprises
PHRX.CNEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 21, 2026 | — | — | — | — |
Q4 2025 | Nov 7, 2025 | — | $-0.00 | — | — |
Q3 2025 | Aug 11, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 30, 2025 | — | $-0.00 | — | — |
Q2 2025 | Apr 29, 2025 | — | $0.00 | — | — |
Q4 2024 | Oct 11, 2024 | — | $-0.00 | — | — |
Q3 2024 | Sep 30, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 30, 2024 | — | $-0.01 | — | — |
Q1 2024 | Jan 4, 2024 | — | $-0.04 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-0.21 | — | — |
Q2 2023 | Jun 30, 2023 | — | $-0.01 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.01 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.02 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.01 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.03 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.00 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.04 | — | — |
Latest News
Frequently Asked Questions about PHRX.CN
What is PHRX.CN's current stock price?
What is the analyst price target for PHRX.CN?
What sector is Pharmadrug Inc. in?
What is PHRX.CN's market cap?
Does PHRX.CN pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PHRX.CN for comparison